Alimentiv is a global CRO with a singular focus: advancing therapies for patients with gastrointestinal diseases. GI is our WHY and for more than 30 years that purpose has driven our scientific rigour, operational excellence, and deep therapeutic expertise, including supporting more than 70% of IBD compounds in development.
We operate as a private, profit-with-purpose company, channeling our commercial success back into scientific research, technology, and our people. With approximately 700 people across multiple countries and three service lines, we are growing deliberately, and the capability of our leaders and our organization is central to how we get there.
If you want to do meaningful work, build something real, and invest back in research that changes lives — we want to meet you!
Positions available: 2
Location: Remote, Canada

Industry-leading specialty GI contract research organization (CRO) transforming clinical trial outcomes and accelerating the development of life-changing therapies. We bring together deep GI expertise, advanced medical imaging solutions, clinical operation excellence and cutting-edge precision medicine/laboratory services.
With a global network of 5,000+ sites in >60 countries and growing, we expedite study activation and maximize patient enrollment, ensuring efficient and impactful clinical trials. Trusted by pharmaceutical and biotech partners, we support over 70% of all IBD compounds in development today – delivering customized end-to-end solutions to bring novel therapies to market.
As a full-service CRO, our offering is tailored to meet your specific clinical research needs:
• Clinical Trial Services
• Medical Monitoring
• Medical Imaging Solutions
• Medical Research & Development
• Medical Writing
• Precision Medicine/Biomarkers
• Clinical Pharmacology
• Histopathology via Specialty Lab, AcelaBio
• Spatial Biology
• Statistics
• Real-World Evidence
Headquartered in London, Ontario, Alimentiv operates with globally across Canada, the US, Europe, Asia-Pacific, and Latin America.